Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin in refractory partial epilepsy (1008-008)
NCT00141414Phase 2Completed
- Sponsor
- Pfizer
- Start
- Nov 1997
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial of pregabalin in epilepsy, sponsored by Pfizer. Primary endpoint: Safety. Started Nov 1997; status: completed.
02
Drugs
pregabalin
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00141414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00141414.